Psoriasis
Audio
Systemic Agents on the Horizon for Psoriasis
Dr. George Han discusses new and upcoming systemic agents for the treatment of psoriasis from the resident's perspective, including novel...
Article
Is There a Potential Benefit of Expressive Writing for Dermatology Patients?
A diagnosis of a chronic and/or serious medical condition can be a traumatic experience. Patients may experience not only intrusive thoughts but...
Article
Biologics in Dermatology Beyond Psoriasis
Biologic agents, or protein-based drugs derived from living cells, are becoming commonplace in dermatology for the treatment of psoriasis, but...
News
New treatments for psoriatic arthritis are changing management
Article
Unmet Needs in Psoriasis
The concept of unmet needs in psoriasis is not new. We are aware that both patients and physicians feel there are gaps in the management and...
Conference Coverage
Apremilast appears to have multiple, lasting benefits in psoriatic arthritis
Key clinical point: Apremilast maintained its efficacy and safety profile through 1 year of treatment.Major finding: At 52 weeks, 55%-63% of...
News
Humira, Enbrel costs highest in the United States
Clinical Topics & News
Alopecia Areata Universalis Complicating Daclizumab Therapy for Uveitis
Alopecia areata (AA) is a complication of biologic therapy with several anti–tumor necrosis factor (TNF) inhibitors and efalizumab for the...
Article
Practice Question Answers: Medications in Dermatology, Part 2
This fact sheet served to tabulate important data points about an array of immunomodulatory pharmacologic agents.
Article
Medications in Dermatology, Part 2: Immunosuppressives
As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review...